The global artificial womb facility market is anticipated to grow at a considerable CAGR of 8.9% during the forecast period. The market is mainly driven by the increasing contribution of research institutes, and the increasing availability of artificial womb facilities globally. For instance, in March 2021, a study published in the journal Nature described removing embryos from the uteruses of mice at 5 days of gestation and growing them for 6 more days in artificial wombs. The artificial womb opens a new window into how gene mutations or deletions affect fetal development. Researchers watch individual cells migrate to their ultimate destinations, and they directly created mouse embryos from mouse fibroblasts, and connective tissue cells, making early embryos without starting with a fertilized egg.
Browse the full report description of “Artificial Womb Facility Market Size, Share & Trends Analysis Report by Technology (Bioreactors, Extrauterin Support Devices, and Other Advanced Technologies), By Application (Prenatal Care and Neonatal Care), and by End-User (Super-Specialty Hospitals, Neonatal Care Centers, Research Centers, and In-Vitro Fertilization Centers (IVF)), Forecast Period (2022-2030)” at https://www.omrglobal.com/industry-reports/artificial-womb-facility-market
Additionally, in December 2022, A biotechnologist in Germany developed the world’s first artificial womb facility, and it lets to choose a baby’s characteristics from a menu. EctoLife can grow 30,000 babies a year, it is powered entirely by renewable energy. According to the World Health Organization, every year around 300,000 women die from pregnancy complications. EctoLife artificial womb is designed to alleviate human suffering and reduce the chances of C-sections. “EctoLife allows the baby to develop in an infection-free environment. The pods are made of materials that prevent germs from sticking to their surfaces. Every growth pod features sensors that monitor the baby’s vital signs, including heartbeat, temperature, blood pressure, breathing rate and oxygen saturation. The artificial intelligence-based system also monitors the physical features of the baby and reports any potential genetic abnormalities. Moroever, in August 2022, Renewal Bio, unveiled new advances in stem-cell technology and artificial wombs demonstrated by Jacob Hanna, a biologist at the Weizmann Institute of Science in Rehovot. Hanna showed that starting with mouse stem cells, the lab form highly realistic-looking mouse embryos and keep them growing in a mechanical womb for several days until they developed beating hearts, flowing blood, and cranial folds. It’s the first time such an advanced embryo has been mimicked without sperm, eggs, or even a uterus.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Technology
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Juno Perinatal Healthcare, Sera Prognostics, Inc., TissUse GmbH, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Artificial Womb Facility Market Report Segment
By Technology
By Application
By End-User
Global Artificial Womb Facility Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/artificial-womb-facility-market